Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 5489523, 7 pages
https://doi.org/10.1155/2017/5489523
Research Article

Significant Improvement Selected Mediators of Inflammation in Phenotypes of Women with PCOS after Reduction and Low GI Diet

1Department of Biochemistry and Human Nutrition, Pomeranian Medical University, Szczecin, Poland
2Clinic of Gynecology and Urogynecology, Pomeranian Medical University, Szczecin, Poland

Correspondence should be addressed to Małgorzata Szczuko; lp.ude.mup@okuzczs.atazroglam

Received 4 February 2017; Revised 2 April 2017; Accepted 6 April 2017; Published 5 June 2017

Academic Editor: Vera L. Petricevich

Copyright © 2017 Małgorzata Szczuko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Carmina, “Diagnosis of polycystic ovary syndrome: from NIH criteria ESHRE-ASRM,” Minerva Ginecologica, vol. 56, no. 1, pp. 1–6, 2004. View at Google Scholar
  2. D. Szydlarska, W. Grzesiuk, and E. Barandziak, “Controversies in the pathogenesis of polycystic ovary syndrome,” Endokrynologia, Otyłość i Zaburzenia Przemiany Materii, vol. 6, no. 3, pp. 141–146, 2010. View at Google Scholar
  3. M. Szczuko, M. Zapałowska-Chwyć, A. Drozd, D. Maciejewska, A. Starczewski, and E. Stachowska, “Effect of IGF-I and TNF-α on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-α,” Gynecological Endocrinology, vol. 32, no. 9, pp. 714–717, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Szczuko, M. Zapałowska-Chwyć, D. Maciejewska, A. Drozd, A. Starczewski, and E. Stachowska, “High glycemic index diet in PCOS patients. The analysis of IGF I and TNF-α pathways in metabolic disorders,” Medical Hypotheses, vol. 96, pp. 42–47, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Stawarska, A. Białek, I. Stanimirova, T. Stawarski, and A. Tokarz, “The effect of conjugated linoleic acids (CLA) supplementation on the activity of enzymes participating in the formation of arachidonic acid in liver microsomes of rats—probable mechanism of CLA anticancer activity,” Nutrition and Cancer, vol. 67, no. 1, pp. 145–155, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Z. Nowak, “Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty AIDS,” Postępy Higieny i Medycyny Doświadczalnej, vol. 64, pp. 115–132, 2010. View at Google Scholar
  7. P. C. Calder, “Omega-3 fatty acids and inflammatory processes,” Nutrients, vol. 2, no. 3, pp. 355–374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Jelińska, I. Gielecińska, H. Mojska, and A. Tokarz, “Validation of the determination of selected eicosanoids using LC-MS/MS technique,” Bromatologia i Chemia Toksykologiczna, vol. 3, pp. 943–948, 2012. View at Google Scholar
  9. D. J. Ross, G. Hough, S. Hama et al., “Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension,” Pulmonary Circulation, vol. 5, no. 4, pp. 640–648, 2015. View at Publisher · View at Google Scholar
  10. L. A. Bojić, D. G. McLaren, A. C. Harms et al., “Quantitative profiling of oxylipins in plasma and atherosclerotic plaques of hypercholesterolemic rabbits,” Analytical and Bioanalytical Chemistry, vol. 408, no. 1, pp. 97–105, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Wang, S. Strandgaard, J. Iversen, and C. S. Wilcox, “Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension,” The American Journal of Physiology, vol. 296, no. 2, pp. R195–R200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Zhao and C. R. E. Funk, “Lipoxygenase pathways in atherosclerosis pathogenesis,” Trends in Cardiovascular Medicine, vol. 14, no. 5, pp. 191–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. V. Mahipal, J. Subhashini, M. C. Reddy et al., “Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis,” Biochemical Pharmacology, vol. 74, no. 2, pp. 202–214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Maciejewska, P. Ossowski, A. Drozd et al., “Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease—a pilot study,” Prostaglandins & Other Lipid Mediators, vol. 121, Part B, pp. 184–189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Vangaveti, B. T. Baune, and R. L. Kennedy, “Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis,” Therapeutic Advances in Endocrinology Metabolism, vol. 1, no. 2, pp. 51–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. N. Vangaveti, V. M. Shashidhar, C. Rush et al., “Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner,” Lipids, vol. 49, no. 12, pp. 1181–1192, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. G. E. Grant, J. Rokach, and W. S. Powell, “5-okso-ETE and Oxe receptor; 5-okso-ETE i receptor Oxe,” Prostaglandins & Other Lipid Mediators, vol. 89, no. 3-4, pp. 98–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Rossaint, J. L. Nadler, K. Ley, and A. Zarbock, “Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury,” Critical Care, vol. 16, no. 5, p. R166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. L. T. Kang and J. Y. Vanderhoek, “Characterization of specific intracellular binding sites for 5-hydroxyeicosatetraenoic acid (15-HETE) on rat basophilic leukemia cells,” Biochimica et Biophysica Acta, vol. 1256, no. 3, pp. 297–304, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. C. N. Serhan, “Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators,” Journal of Periodontology, vol. 79, 8 Supplement, pp. 1520–1526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Raszeja-Wyszomirska, K. Safranow, M. Milkiewicz, P. Milkiewicz, A. Szynkowska, and E. Stachowska, “Lipidic last breath of life in patients with alcoholic liver disease,” Prostaglandins & Other Lipid Mediators, vol. 99, no. 1-2, pp. 51–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Ciepiela, T. Bączkowski, A. Drozd, A. Kazienko, E. Stachowska, and R. Kurzawa, “Arachidonic and linoleic acid derivatives impact oocyte ICSI fertilization—a prospective analysis of follicular fluid and a matched oocyte in a ‘one follicle—one retrieved oocyte—one resulting embryo’ investigational setting,” PLoS One, vol. 10, no. 3, article e0119087, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Qiu, A. Gabrielsen, H. E. Agardh, M. Wan, A. Wetterholm, and C. H. Wong, “Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 21, pp. 8161–8166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. López-Parra, E. Titos, R. Horrillo et al., “Regulatory effects of arachidonate 5-lipoxygenase onhepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice,” Journal of Lipid Research, vol. 49, no. 12, pp. 2513–2523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Subramanian, L. Goodspeed, S. Wang, J. Kim, L. Zeng, and N. I. Ioannou, “Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice,” Journal of Lipid Research, vol. 52, no. 9, pp. 1626–1635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Beresewicz and M. Kurzelewski, “Pathophysiology of acute coronary syndrome,” Medipress Kardiologia, vol. 8, pp. 3–11, 2001. View at Google Scholar
  27. K. Zha, C. Zuo, A. Wang et al., “LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation,” Lipids in Health and Disease, vol. 14, no. 1, p. 95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. X. Yuan, S. I. Rapoport, S. J. Soldin et al., “Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry,” Biomedical Chromatography, vol. 27, no. 4, pp. 422–432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Obinata and T. Izumi, “G2A as a receptor for oxidized free fatty acids,” Prostaglandins & Other Lipid Mediators, vol. 89, no. 3-4, pp. 66–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Rolin and A. A. Maghazachi, “Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis,” Journal of Leukocyte Biology, vol. 95, no. 4, pp. 575–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. F. Parkinson, “Lipoxin and synthetic lipoxin analogs: an overview of antiinflammatory functions and new concepts in immunomodulation,” Inflammation & Allergy Drug Targets, vol. 5, no. 2, pp. 91–106, 2006. View at Publisher · View at Google Scholar · View at Scopus